There are many opportunities for women to excel at Centenary. Below are some recent examples of their achievements.
This annual Award recognises young, inspiring researchers Australia-wide who are tackling the big questions in the biomedical space and who are helping accelerate medical research advances for the betterment of all of our communities.
In 2019, Dr Elinor Hortle from the Centenary Institute was awarded the ‘Bayer Innovation Award’ for her discovery that platelets (cells that help the body form clots to stop bleeding) have an active role in the development of tuberculosis (TB). This provided evidence that cheap, safe, and easily available antiplatelet drugs like aspirin might provide an effective treatment for TB.
The ‘Harvard Club of Australia Foundation Travel Prize’ for the purpose of travelling to Harvard University, Boston, Massachusetts, USA to explore opportunities for collaboration, also went to Dr Elinor Hortle. Read more
In 2017 and 2018 the Centenary Institute partnered with the Bank of Queensland to present the Bank of Queensland Gender Equity Early Career Award.
Associate Professor Jodie Ingles, recipient of the Award In 2017: Jodie has published results of a world-first study on the effects of sudden cardiac death on loved ones left behind. These families must deal with the grief of unexpected death and the genetic risk for other family members and future generations. Jodie also established the first ever Australian National Genetic Heart Disease Registry, to provide a research resource, education and Improved awareness for health professionals and families at risk. Read more
Dr Shweta Tlkoo, recipient of the Award In 2018: Shweta’s work focuses on exploring a subset of macrophages (a type of white blood cell) In breast cancer progression and metastasis, with the aim of developing more effective treatment strategies to combat the disease. She will use the Award grant to develop a deeper understanding of how the body’s defence mechanism fails to prevent cancer spread and resurgence, and how a new system can be modulated to prevent this. Read more
Check out below what our women of Centenary are up to!
Research led by the Centenary Institute has shown that a healthy weight and coffee consumption may help lower the risk of high-risk drinkers developing alcohol-induced cirrhosis (scarring of the liver), which causes approximately 300,000 deaths globally each year.
Clinical Associate Professor Seth believes that their findings may have major public health consequences. Read more
The Future Leader Fellowship at the Centenary Institute has been jointly awarded to two outstanding researchers for 2020–Dr Jessamy Tiffen (left) from the Institute’s Melanoma Oncology and Immunology Program and Dr Shweta Tikoo (right) from the Institute’s Immune Imaging Program. They will both share the Fellowship as well as its associated support packages. Read more
Researchers from the Centenary Institute have discovered a potential new therapy for cerebral cavernous malformations (CCMs), a devastating disease that often affects young people and can result in stroke and seizures.
In the study, Professor Jenny Gamble and collaborators were able to show that a protein called VE-cadherin, critical to maintaining a healthy blood vessel lining, was seen at lower levels in mice with CCM lesions. Read more
Centenary Institute PhD candidate Ms Aster Pijning has won the jury’s vote for first prize as well as the people’s choice prize for her efforts at the Sydney Catalyst Perfect Pitch Competition.
The competition was a chance for participating researchers to refine their ‘elevator pitch’ and to describe their research skills and experience to a virtual audience and a panel of judges in 60 seconds. Read more
Scientists from the Centenary Institute have developed a new therapeutic strategy that could potentially help the fight against advanced-stage melanoma.
Senior study author Dr Shweta Tikoo notes that there is an unmet need for novel therapeutic strategies which can be developed in the battle against advanced melanoma. Read more
Two Centenary Institute scientists, Associate Professor Jodie Ingles (pictured left) and Dr Renjing Liu, are recipients of this year’s Sydney Research Accelerator (SOAR) prizes which support outstanding University of Sydney early and mid-career researchers. Read more
An Australian sea sponge could hold the key to successfully combatting the deadly disease tuberculosis (TB), a new study from the Centenary Institute and the University of Sydney suggests.
Australian medical researchers from the Centenary Institute and the University of Sydney have successfully developed and tested a new type of vaccine targeting tuberculosis (TB), the world’s top infectious disease killer.